Dr. Christopher Woelk arrived at the University of Southampton as a Reader in Genomics and Bioinformatics in 2013. Dr. Woelk’s laboratory uses genomics technologies (i.e. RNA-Seq) to investigate the mechanism of human disease, and to develop diagnostic and prognostic classifiers. Active areas of research in the Woelk lab include the following: HIV eradication, reverse vaccinology, asthma, schizophrenia and post-traumatic stress disorder. The long-term research goals of the Woelk lab are to develop a diagnostic test for a human disease (e.g. schizophrenia) that becomes widespread in clinical use, and develop a new subunit vaccine that provides widespread protection against a bacterial pathogen (e.g. Salmonella spp.).
Prior to moving to the University of Southampton, Dr. Woelk received a 1st in Biochemistry and Genetics from the University of Nottingham, and a PhD from the University of Oxford where he studied the molecular evolution of viruses and first acquired skills related to computational biology. Dr. Woelk completed his postdoctoral studies looking at the host response to HIV infection at the University of California in San Diego (UCSD) where he rose through the ranks to the level of Associate Professor.